维普中文期刊产品整合服务
33篇 您的检索式:作者名="Cutolo R"
    题名 作者 年代 出处 被引量
1Prednisone chrono-therapy显示文摘SPIES C M CUTOLO M STRAUB R H 2011Clin Exp Rheumatol2011,29,568:1
2Different roles for androgens and estrogens in thesuscep tibility to autoimmune rheumatic diseases显示文摘Cutolo M Wilder R L 2000Rheum Dis Clin North Am2000,26,4:1
3Regulation of glu-eoeortieoids by the central nervous system显示文摘CUTOLO M BUTI'GEREIT F STRAUB R H 2011Clin Exp Rhenma-tol2011,29,568:1
4Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP- 690, 550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs显示文摘Fleischmann R Cutolo M Genovese MC 2012Arthritis Rheum2012,64,3:1
5Energy reg-ulation and neuroendocrine-immune control in chronic inflamma-tory diseases显示文摘STRAUB R H CUTOLO M BUTTGEREIT F 2010J Intern Med2010,267,6:1
6Color changes in burley tobacco curing as affected by N fertilization显示文摘Tremola M G Interlandi G Carotenuto R Piro F Leone V Cutolo R 2001Tobacco2001,9,:1
7Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone显示文摘Alten R D?ring G Cutolo M 0,,10:1
8Estrogen metabolism and autoimmunity显示文摘CUTOLO M SULLI A STRAUB R H 2012Autoimmun Rev2012,11,67:1
9Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs显示文摘Fleischmann R Cutolo M Genovese MC 0,,03:1
10Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune disea-ses a role for misguided energy regulation 显示文摘STRAUB R H BUTFGEREIT F CUTOLO M 2011Clin Exp Rheu-matol2011,29,568:1
11Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs显示文摘Fleischmann R Cutolo M Genovese MC 0,,03:1
12Different roles for androgeus and estrigens in the susceptibility to autommune rheumatic diseases 显示文摘CUTOLO M WILDER R L 2000Rheum Dis Clin North Am2000,26,:1
13Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib ( CP- 690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifylng antirheumatic drugs 显示文摘FLEISCHMANN R CUTOLO M GENOVESE MC 2012Arthritis Rheum2012,64,3:1
14Phase II i,dose-ranging study of the oral JAK inhibitor tofacitinib ( CP-690 ,550) or adalimumab monotherapy versus placebo in pa-tients with active rheumatoid arthritis with an inadequate re-sponse to disease-modifying antirheumatic drugs显示文摘Fleischmann R Cutolo M Genovese MC 2012Arthri-tis Rheum^2012^ 64(3) : 617-6292012,64,3:1
15The immunomodulatory effects of estrogens:clinical relevance in immune-mediated rheumatic diseases显示文摘Cutolo M Brizzolara R Atzeni F 2010Ann N Y Acad Sci2010,1193,:1
16Estrogen metabolism and autoimmunity 显示文摘Cutolo M Sulli A Straub R I-1 2011Autoimmun Rev2011,,:1
17Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib(CP-690,550)or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs显示文摘Fleischmann R Cutolo M Genovese MC 2012Arthritis Rheum2012,64,3:1
18Hypothalamus-pituitaryadrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone显示文摘Alten R Dring G Cutolo M 2010J Rheumatol2010,37,10:1
19Phase ]Ib dose- ranging study of the oral JAK inhibitor tofacitinib (CP-690, 550) or adalimumab monotherapy versus placebo in patients with ac- tive rheumatoid arthritis with an inadequate response to disease- modifying antirheumatic drugs 显示文摘Fleischmann R Cutolo M Genovese MC 2012Arthritis Rheum2012,64,3:1
20Prednisone chronotherapy显示文摘Spies C M Cutolo M Straub R H 2011Clin Exp Rheumatol2011,29,68:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费